| ID | Type | Location (GRCh37) | Location (GRCh38) | Length | GC content |
|---|---|---|---|---|---|
| hsa_chr4_0257400 | Intergenic-Intergenic | chr4:166218791-166220799 | chr4:165297639-165299647 | 228 nt | 0.4649 |
| hsa_chr4_0257500 | Intergenic-Intergenic | chr4:166222245-166222702 | chr4:165301093-165301550 | 458 nt | 0.3253 |
| hsa_KLHL2_0004500 | Intron-Exon-Intron | chr4:166224089-166226877 | chr4:165302937-165305725 | 2789 nt | 0.3937 |
| hsa_KLHL2_0004600 | Intron-Exon-Intron | chr4:166224132-166226877 | chr4:165302980-165305725 | 2746 nt | 0.3948 |
| hsa_KLHL2_0004700 | Intron-Exon-Intron | chr4:166224926-166228246 | chr4:165303774-165307094 | 250 nt | 0.4320 |
| hsa_KLHL2_0005100 | Exon-Exon | chr4:166226760-166235318 | chr4:165305608-165314166 | 339 nt | 0.4543 |
| hsa_KLHL2_0005200 | Exon-Exon | chr4:166226834-166231740 | chr4:165305682-165310588 | 80 nt | 0.5500 |
| hsa_KLHL2_0005400 | Exon-Exon | chr4:166231705-166232717 | chr4:165310553-165311565 | 300 nt | 0.4700 |
| hsa_KLHL2_0005500 | Exon-Exon | chr4:166231705-166235318 | chr4:165310553-165314166 | 441 nt | 0.4512 |
| hsa_KLHL2_0005700 | Exon-Exon | chr4:166234390-166238995 | chr4:165313238-165317843 | 141 nt | 0.4113 |
A study in humans identified the circKLHL2 as a potential biomarker for immune-mediated demyelinating disease, where its levels in cerebrospinal fluid exosomes were specifically characterized [Misir et al. DOI:10.1038/s41418-022-00948-7]. A study in mice and human patients demonstrated that the circKLHL2 may expedite sepsis-induced acute lung injury by adjusting the miR-29b-3p/ROCK axis [Xu et al. DOI:10.1080/01902148.2024.2429184].